ArticleInternational journal of general medicine2026

Multi-Omics Prioritization and Clinical Evaluation of CYP4V2 as a Candidate Biomarker in Venous Thromboembolism.

Chen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.